SCHEMBL24729618

SCHEMBL24729618

O=C(Nc1cc(NCc2cn3cc(C4CC4)ccc3n2)ncn1)OCc1cc(Cl)ccn1

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KLKB1 P03952 19/20 0.41
▸ METTL3 Q86U44 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24729482 0.88 KLKB1 (0.40) KLKB1METTL3
SCHEMBL29927020 0.88 KLKB1 (0.40) KLKB1METTL3
SCHEMBL24729701 0.87 KLKB1 (0.45) KLKB1METTL3
SCHEMBL24729588 0.87 KLKB1 (0.40) KLKB1METTL3
SCHEMBL29927451 0.87 KLKB1 (0.40) KLKB1METTL3
SCHEMBL24729622 0.85 METTL3 (0.38) KLKB1METTL3
SCHEMBL29141788 0.85 METTL3 (0.43) KLKB1METTL3
SCHEMBL29141783 0.84 METTL3 (0.42) KLKB1METTL3
SCHEMBL24729591 0.82 KLKB1 (0.39) KLKB1
SCHEMBL24729590 0.82 KLKB1 (0.38) KLKB1METTL3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308227-A1 IMIDAZOPYRIDINYL INHIBITORS OF PLASMA KALLIKREIN Takeda Pharmaceutical Company Limited (JP) 2024-01-24 — — EP disclosed
WO-2022197755-A1 IMIDAZOPYRIDINYL INHIBITORS OF PLASMA KALLIKREIN SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2022-09-22 — — WO disclosed
WO-2022197755-A1 IMIDAZOPYRIDINYL INHIBITORS OF PLASMA KALLIKREIN SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2022-09-22 — — WO disclosed
Send feedback